Yang C - Search Results

1

Immune checkpoint B7-H3 is a potential therapeutic target in prostate cancer.

Shen Q, Zhou K, Lu H, Zhang J, Xu Q, Zhang C, Yang C, Mao L. Shen Q, et al. Among authors: yang c. Discov Oncol. 2024 Dec 22;15(1):822. doi: 10.1007/s12672-024-01674-x. Discov Oncol. 2024. PMID: 39709589 Free PMC article. Review.

2

Exosomes in diagnosis and therapy of prostate cancer.

Pan J, Ding M, Xu K, Yang C, Mao LJ. Pan J, et al. Among authors: yang c. Oncotarget. 2017 Jun 17;8(57):97693-97700. doi: 10.18632/oncotarget.18532. eCollection 2017 Nov 14. Oncotarget. 2017. PMID: 29228644 Free PMC article. Review.

3

SATB1 is a Novel Molecular Target for Cancer Therapy.

Ding M, Pan J, Guo Z, Liu Q, Yang C, Mao L. Ding M, et al. Among authors: yang c. Cancer Invest. 2018 Jan 2;36(1):28-36. doi: 10.1080/07357907.2018.1423688. Epub 2018 Jan 30. Cancer Invest. 2018. PMID: 29381393 Review.

4

Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation.

Mao LJ, Kan Y, Li BH, Ma S, Liu Y, Yang DL, Yang C. Mao LJ, et al. Among authors: yang c, yang dl. Front Oncol. 2020 Apr 3;10:421. doi: 10.3389/fonc.2020.00421. eCollection 2020. Front Oncol. 2020. PMID: 32318337 Free PMC article.

5

Prostate cancer stem cells: an updated mini-review.

Zhou K, Lu H, Zhang J, Shen Q, Liu P, Xu Q, Yang C, Mao L. Zhou K, et al. Among authors: yang c. J Cancer. 2024 Oct 28;15(20):6570-6576. doi: 10.7150/jca.100604. eCollection 2024. J Cancer. 2024. PMID: 39668824 Free PMC article. Review.

6

Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer.

Mao LJ, Ding M, Xu K, Pan J, Yu H, Yang C. Mao LJ, et al. Among authors: yang c. J Cancer. 2018 Oct 22;9(23):4391-4397. doi: 10.7150/jca.26437. eCollection 2018. J Cancer. 2018. PMID: 30519344 Free PMC article.

7

CART cell therapy for prostate cancer: status and promise.

Yu H, Pan J, Guo Z, Yang C, Mao L. Yu H, et al. Among authors: yang c. Onco Targets Ther. 2019 Jan 3;12:391-395. doi: 10.2147/OTT.S185556. eCollection 2019. Onco Targets Ther. 2019. PMID: 30655675 Free PMC article. Review.

8

Current state of biomarkers for the diagnosis and assessment of treatment efficacy of prostate cancer.

Liu J, Li Y, Yang D, Yang C, Mao L. Liu J, et al. Among authors: yang c, yang d. Discov Med. 2019 Jun;27(150):235-243. Discov Med. 2019. PMID: 31421692 Free article. Review.

9

Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer.

Mao L, Yu H, Ma S, Xu Z, Wei F, Yang C, Zheng J. Mao L, et al. Among authors: yang c. J Cancer. 2021 Jan 25;12(6):1846-1852. doi: 10.7150/jca.46868. eCollection 2021. J Cancer. 2021. PMID: 33613773 Free PMC article.

10

Emerging Roles of Long Non-coding RNAs as Novel Biomarkers in the Diagnosis and Prognosis of Prostate Cancer.

Kan Y, Li B, Yang D, Liu Y, Liu J, Yang C, Mao L. Kan Y, et al. Among authors: yang c, yang d. Discov Med. 2021 Jul-Aug;32(165):29-37. Discov Med. 2021. PMID: 35219354 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,331 results

Search Page

Filters